Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by monty613on Apr 25, 2022 9:18am
123 Views
Post# 34628451

RE:RE:RE:RE:RE: cantechletter

RE:RE:RE:RE:RE: cantechletter
Bondgal wrote:
Minus EPS is Minus EPS 


sorry, but  EPS is the worst metric to be evaluating this company on and the market is smart enough to look at FCF and EBITDA over GAAP earnings for a growth story. the company went on an acquisition binge in 2021 (one-time expenses galore) and they also have a meaningful non-cash expense in the form of Dep/Amort due to the way CRH Medical joint ventures are structured. 

this company is ripe for PE involvement because WELL and CRH, their main drivers, can grow with the use of senior bank debt only.
<< Previous
Bullboard Posts
Next >>